GLP-1 Insurance Coverage Lost 2026: 41 Million Americans Dropped from Ozempic and Wegovy — What to Do Now

# GLP-1 Insurance Coverage Lost 2026: 41 Million Americans Dropped from Ozempic and Wegovy — What to Do Now

> **Quick answer:** Since January 2026, major insurers including Blue Cross Blue Shield, Cigna, and UnitedHealthcare have dropped GLP-1 coverage for weight loss, leaving 41 million Americans without coverage for Wegovy or Zepbound. Your options include manufacturer direct programs (as low as $149/month for Wegovy), the Medicare GLP-1 Bridge launching July 1, 2026, patient assistance programs, and prior authorization appeals. This guide covers every route available.

*This article is for informational purposes only and does not constitute financial or medical advice. Consult a qualified healthcare provider and financial advisor for decisions about your medication and health coverage.*

GLP-1 insurance coverage lost 2026 is not a minor story — it is a mass coverage collapse affecting one in eight commercially insured Americans. If your insurer quietly dropped Ozempic, Wegovy, or Zepbound from your formulary this year, you are not alone, and you are not out of options.

## The Scale of the Coverage Collapse

The numbers are stark. According to GoodRx research published in April 2026, the number of commercially insured Americans with no coverage for Wegovy increased by **42% in a single year**. In total, over **41 million people** now have no commercial insurance coverage for GLP-1 weight-loss medications.